Alison (Ali) Holland is Head of Decentralized Clinical Trials at Medable and is chartered to design and expand the end-to-end capabilities.
What started as the industry’s effort to remedy a pandemic emergency in 2020 and optimize clinical trial execution blossomed into something much more transformative. The decentralized model gave birth to a new healthcare environment, where digital enablement empowers patient choice. If 2020 was the match, 2021 was the fuel that enabled the spread of a new model for a new era of patient care today.
The decentralized model has opened doors to more patients and reduced access disparity in healthcare to improve overall outcomes.
Clinical research professionals increasingly are cognizant that achieving more patient-centric trials and increasing diversity in research are essential to effective results.
